Lv1
70 积分 2022-12-15 加入
In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response
1个月前
已完结
An FDA oncology analysis of antibody-drug conjugates
3个月前
已完结
B cell-targeted therapies in systemic lupus erythematosus
3个月前
已完结
Hypersensitivity and Immune-related Adverse Events in Biologic Therapy
6个月前
已完结
Nociceptive neurons promote gastric tumour progression via a CGRP–RAMP1 axis
7个月前
已完结
Targeting autophagy plus high-dose CDK4/6 inhibitors in advanced HR+HER2− breast cancer: A phase 1b/2 trial
7个月前
已完结
Proteome‐Wide Data Guides the Discovery of Lysine‐Targeting Covalent Inhibitors Using DNA‐Encoded Chemical Libraries
7个月前
已完结
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
7个月前
已完结
Docetaxel in Second-Line Treatment of non—small-Cell Lung Cancer
7个月前
已完结
Docetaxel in Second-Line Treatment of non—small-Cell Lung Cancer
7个月前
已完结
皖公网安备34019202002308
